Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3
Authors
Keywords
-
Journal
Molecular Oncology
Volume 10, Issue 9, Pages 1485-1496
Publisher
Wiley
Online
2016-09-03
DOI
10.1016/j.molonc.2016.08.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Distinct Breast Cancer Stem Cell Populations Based on Single-Cell Analyses of Functionally Enriched Stem and Progenitor Pools
- (2016) Nina Akrap et al. Stem Cell Reports
- Cellular Effect of Curcumin and Citral Combination on Breast Cancer Cells: Induction of Apoptosis and Cell Cycle Arrest
- (2015) Pinaki B. Patel et al. Journal of Breast Cancer
- Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma
- (2015) Lili Yue et al. MELANOMA RESEARCH
- Formulation, Characterization, and Antitumor Properties of Trans- and Cis-Citral in the 4T1 Breast Cancer Xenograft Mouse Model
- (2015) San Zeng et al. PHARMACEUTICAL RESEARCH
- Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
- (2015) Ina Kurth et al. Oncotarget
- A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations
- (2015) Claudia Canino et al. Oncotarget
- Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway
- (2015) Dan Han et al. Oncotarget
- Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide
- (2015) Joanna Triscott et al. Oncotarget
- Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
- (2015) Peng Liu et al. Oncotarget
- Combining Amine Metabolomics and Quantitative Proteomics of Cancer Cells Using Derivatization with Isobaric Tags
- (2014) J. Patrick Murphy et al. ANALYTICAL CHEMISTRY
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- (2014) D. Raha et al. CANCER RESEARCH
- Essential Role of Aldehyde Dehydrogenase 1A3 for the Maintenance of Non-Small Cell Lung Cancer Stem Cells Is Associated with the STAT3 Pathway
- (2014) C. Shao et al. CLINICAL CANCER RESEARCH
- Involvement of aldehyde dehydrogenase 1A2 in the regulation of cancer stem cell properties in neuroblastoma
- (2014) TRI BUDI HARTOMO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma
- (2014) Xu Qian et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling
- (2014) Paola Marcato et al. Molecular Oncology
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma
- (2013) Kefeng Wang et al. MEDICAL ONCOLOGY
- ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma
- (2013) Lang Yang et al. MODERN PATHOLOGY
- Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
- (2013) P. Mao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
- (2012) P Liu et al. BRITISH JOURNAL OF CANCER
- Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
- (2012) Xiao Li et al. Journal of Thoracic Oncology
- ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
- (2012) Yuchun Luo et al. STEM CELLS
- The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance
- (2011) Jan S. Moreb et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis
- (2011) Christel van den Hoogen et al. CLINICAL & EXPERIMENTAL METASTASIS
- Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity and outcome to neoadjuvant chemotherapy
- (2011) Thaer Khoury et al. MODERN PATHOLOGY
- Twist2 contributes to breast cancer progression by promoting an epithelial–mesenchymal transition and cancer stem-like cell self-renewal
- (2011) X Fang et al. ONCOGENE
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
- (2010) Paola Marcato et al. STEM CELLS
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells
- (2009) Wahid Chaouki et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53-Mediated Mouse Mammary Tumors
- (2008) N. Shafee et al. CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started